Governance Classic Home
Zydus Lifesciences LtdPharmaceuticalsINE010B01027Consolidated₹1188.10-52.50 (-4.23%)
Valuation
Market Cap₹1.20L Cr
TTM PE28.53x
Forward PE28.49x
PEG-3.96
Book Value₹269.43
P/B4.41x
TTM EPS₹41.64
Fwd EPS₹41.71
TTM Revenue₹30.38K Cr
TTM PAT₹4.28K Cr
TTM EBITDA₹8.19K Cr
TTM EBIT₹6.17K Cr
Last Qtr PAT₹927.70 Cr
Last Qtr EBITDA₹1.89K Cr
Last Qtr EBIT₹1.29K Cr
Profitability
ROE15.79%
ROCE15.53%
TTM NPM14.10%
TTM EBITDA %26.98%
Curr OPM11.54%
Last OPM12.19%
Curr NPM—
Last NPM—
Curr EPS₹9.28
Last EPS₹9.35
Balance sheet
Equity₹100.60 Cr
Reserve₹27.01K Cr
Total Debt₹12,496.00 Cr
D/E0.46x
Interest %20.16%
Curr Interest₹187.00 Cr
Price / range
Close₹1188.10
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-4.23%
1W+1.07%
1M+3.70%
3M+5.14%
6M+31.67%
1Y+22.13%
2Y+18.30%
3Y+103.23%
5Y+141.61%
Diwali+29.92%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue3,482+21.3%2,872.203,740.902,283.602,871.2011,484
Other Income164.60123.70495.10473.80541.501,667.50
Total Income3,646.60+6.9%2,995.904,2362,757.403,412.7013,151.50
Interest101.40103.10115.50116113.80482.90
Expenditure-2,682.60-36.2%-2,540.20-2,018.20-2,344.90-1,969.10-8,602.70
PBDT000000
EBITDA1,056.20-8.3%5871,989.101991,151.903,925.40
Depreciation-155.40-151.90-150.90-144.30-136-561.20
EBIT900.80-11.3%435.101,838.2054.701,015.903,364.20
PBT962.10-33.4%455.702,111352.401,443.604,381.90
Tax-247.60-116.10-389-55.90-287-822.10
Equity99.8099.80100.60100.600100.60
OPM26.3815.2149.8312.7850.2833.32
Net Profit714.50-38.2%339.601,722296.501,156.603,559.80
NPM19.5911.3440.6510.7540.2827.07
EPS7.15-37.8%3.3817.112.9511.4935.38

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue11,484-24.0%15,116.30+39.7%10,818.70+23.9%8,731.60+9.4%7,981.90+2.5%7,790.40
Other Income1,667.50696.201,084.80548.40178.7078.90
Total Income13,151.50-16.8%15,812.50+32.8%11,903.50+28.3%9,280+13.7%8,160.60+3.7%7,869.30
Expenditure-8,602.70-2.8%-8,367.80-9.3%-7,655.10-8.7%-7,044-5.5%-6,677.40-11.4%-5,993.30
Interest-482.90-463.90-390.70-278.20-134.90-70.90
PBDT000000
EBITDA3,925.40-49.3%7,736.30+90.6%4,058.70+65.4%2,454.40+28.0%1,918.10-17.3%2,319.10
Depreciation-561.20-523.90-504.40-488.60-478.70-451.10
EBIT3,364.20-53.4%7,212.40+102.9%3,554.30+80.8%1,965.80+36.6%1,439.40-22.9%1,868
PBT4,381.90-41.1%7,444.70+75.6%4,239.80+108.6%2,032.20+74.6%1,163.90-31.1%1,688.50
Tax-822.10-1,669.80-798.30-503-306-212.30
Equity100.60100.600000
OPM (%)33.3247.0836.0022.0014.0021.00
Net Profit3,559.80-38.4%5,774.90+67.8%3,441.50+125.1%1,529.20+78.2%857.90-41.9%1,476.20
NPM (%)27.0736.5229.0016.0011.0019.00
EPS (Rs)35.38-38.4%57.39+68.7%34.01+125.8%15.06+79.7%8.38-41.9%14.42
CEPS35.3857.3934.0115.068.3814.42

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue7,909.60+29.2%8,0177,5876,864.506,123.2027,148.40
Other Income129.90106.10134.20111.40109509.50
Total Income8,039.50+29.0%8,123.107,721.206,975.906,232.2027,657.90
Interest187156123129.90101.30438.90
Expenditure-6,806.60-50.9%-6,798.30-5,664-5,537.60-4,510.60-20,520.20
PBDT000000
EBITDA1,894.50-6.0%1,929.402,554.401,816.402,015.808,475.10
Depreciation-604.50-554.70-508.40-359.60-301.90-1,408
EBIT1,290-24.7%1,374.702,0461,456.801,713.907,067.10
PBT1,234.20-26.9%1,306.601,659.701,353.401,687.406,621.10
Tax-334-354.20-318.40-388.30-454-1,594.70
Equity99.8099.80100.6000100.60
OPM15.3516.0821.5019.4027.0823.94
Net Profit927.70-25.1%990.201,3411,022.901,238.605,123.50
NPM11.5412.1917.3714.6619.8718.52
EPS9.28-25.8%9.3512.6510.3612.5150.09

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue27,148.40+16.8%23,241.50+18.9%19,547.40+13.4%17,237.40+12.9%15,265.20+1.1%15,102.20
Other Income509.50269.50284.10186.60224.7037.20
Total Income27,657.90+17.6%23,511+18.6%19,831.50+13.8%17,424+12.5%15,489.90+2.3%15,139.40
Expenditure-20,520.20-18.9%-17,264.70-15.0%-15,008.40-5.5%-14,230.10-11.5%-12,764.50-0.9%-12,649.50
Interest-438.90-165.90-81.20-129.90-127-163.50
PBDT000000
EBITDA8,475.10+20.1%7,058.50+31.1%5,384.30+39.5%3,859.90+15.5%3,340.700.0%3,341
Depreciation-1,408-915.80-764.10-722.70-713-724.80
EBIT7,067.10+15.0%6,142.70+33.0%4,620.20+47.3%3,137.20+19.4%2,627.70+0.4%2,616.20
PBT6,621.10+9.9%6,026.70+25.3%4,808.90+85.7%2,589.70-8.8%2,838.10+24.2%2,284.80
Tax-1,594.70-1,411.90-977.50-587.80-511.70-147.20
Equity100.60100.600000
OPM (%)23.9425.6324.2514.8618.3215.09
Net Profit5,123.50+9.6%4,672.60+17.6%3,972.80+89.9%2,091.90-54.7%4,618.30+111.4%2,185
NPM (%)18.5219.8720.0312.0129.8114.43
EPS (Rs)50.09+11.4%44.97+17.9%38.14+97.6%19.30-56.0%43.84+110.4%20.84
CEPS50.0944.9738.1419.3043.8420.84

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2026Final Dividend124 Jul 2026
2025Final Dividend1125 Jul 2025
2024Final Dividend326 Jul 2024
2023Final Dividend628 Jul 2023
2022Final Dividend2.528 Jul 2022
2021Final Dividend3.528 Jul 2021
2020Interim Dividend3.523 Mar 2020
2019Final Dividend3.525 Jul 2019
2018Final Dividend3.531 Jul 2018
2017Interim Dividend3.216 Mar 2017
2016Interim Dividend3.217 Mar 2016
2015Final Dividend1230 Jul 2015
2014Final Dividend917 Jul 2014
2014Interim Dividend7.511 Jun 2013
2012Final Dividend7.526 Jul 2012
2011Final Dividend6.2507 Jul 2011
2010Final Dividend515 Jul 2010
2009Final Dividend4.516 Jul 2009
2008Final Dividend4.510 Jul 2008

Bonus

1
YearRatioEx-Date
20101:205 Apr 2010

Split

1
YearRatioEx-Date
2015Rs.5/- to Rs.1/-06 Oct 2015
Loading company dashboard...
Fetching ratios, charts, and peers